Data / Form D filings / Armune BioScience Inc
Armune BioScience Inc: Form D filings
Armune BioScience Inc, a biotechnology company in Kalamazoo, MI, filed 8 Form D notices with the SEC between 2009 and 2017. The latest, on January 23, 2017, reports $500,000 sold of a $2 million offering to 2 investors.
Find out what Armune BioScience Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 350 East Michigan Ave, Suite 500, Kalamazoo, MI, 49007
- Phone
- (269) 349-8870
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1440372
The full lists. Form D filings in Michigan: 506 rows, $25.30, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 23, 2017 | New notice | $2,000,000 | $500,000 | $1,500,000 | 2 | Jan 13, 2017 | sec.gov |
| Jul 12, 2016 | Amendment | $10,458,789 | $9,705,032 | $753,757 | 47 | Jan 8, 2015 | sec.gov |
| Feb 18, 2016 | Amendment | $9,458,789 | $9,090,032 | $368,757 | 46 | Jan 8, 2015 | sec.gov |
| Jan 20, 2015 | New notice | $8,446,261 | $3,537,583 | $4,908,678 | 30 | Jan 8, 2015 | sec.gov |
| Apr 29, 2013 | Amendment | $2,000,000 | $1,399,999 | $600,001 | 17 | Aug 7, 2009 | sec.gov |
| Jul 3, 2012 | Amendment | $1,500,000 | $1,144,999 | $355,001 | 14 | Aug 7, 2009 | sec.gov |
| Dec 22, 2010 | New notice | $250,000 | $250,000 | $0 | 1 | Dec 14, 2010 | sec.gov |
| Aug 11, 2009 | New notice | $400,000 | $400,000 | $0 | 7 | Aug 7, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Donald R Parfet | Director | |
| James R Sollins | Director | |
| Dennis P Kane | Director | |
| David A Esposito | Executive Officer, Director | |
| Susan R Crookston | Executive Officer |
Other biotechnology companies in Michigan that filed recently
- Dvant Pharma, Inc. $1.2 million · Oct 13, 2026
- iReprogram, Inc offering · Aug 13, 2026
Every Form D from the week of Jan 23, 2017 · All recent filings in Michigan · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Armune BioScience Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.